Veterinary Medicines

Rispoval IBR-Marker InactivatumSuspension for injection for cattle

Authorised
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
Download as PDF

Product identification

Medicine name:
Rispoval IBR-Marker InactivatumSuspension for injection for cattle
Rispoval IBR-Marker Inactivatum, injekcinė suspensija galvijams
Active substance:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (calf)
  • Cattle (heifer)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
    0.01
    titre
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • (ID3) 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 100 millilitre(s)
  • (ID2) 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1794/001-002
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0021/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 28/06/2024
Download

RV1794.pdf

Lithuanian (PDF)
Published on: 26/05/2022
Download